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Fluorescence imaging has gathered interest over the recent years for its real-time
response and high sensitivity. Developing probes for this modality has proven to
be a challenge. Quantum dots (QDs) are colloidal nanoparticles that possess
unique optical and electronic properties due to quantum confinement effects,
whose excellent optical properties make them ideal for fluorescence imaging of
biological systems. By selectively controlling the synthetic methodologies it is
possible to obtain QDs that emit in the first (650–950 nm) and second (1000–
1400 nm) near infra-red (NIR) windows, allowing for superior imaging properties.
Despite the excellent optical properties and biocompatibility shown by someNIR
QDs, there are still some challenges to overcome to enable there use in clinical
applications. In this review, we discuss the latest advances in the application of
NIR QDs in preclinical settings, together with the synthetic approaches and ma-
terial developments that make NIR QDs promising for future biomedical applica-
tions.
INTRODUCTION
Current imaging techniques used in a clinical setting include magnetic resonance imaging (MRI),
computed tomography (CT), positron emission tomography (PET), single-photon emission computed to-
mography (SPECT), and ultrasound. Each of these techniques has strengths and limitations; for example,
MRI can produce high-resolution anatomical and functional images, with high tissue penetration, without
using ionizing radiation, yet suffers from poor image contrast. PET offers a highly sensitive imaging modal-
ity, yet suffers from poor resolution, requires ionizing radiation, and will usually be paired with an anatom-
ical technique such as MRI or CT (Judenhofer et al., 2008). Furthermore, most of these imaging techniques
require large, expensive machines to produce these images, have scanning times on the order of minutes
to hours, and have significant image reconstruction periods associated with them (Alkhybari et al., 2018;
Leigh et al., 2002). Ultrasound stands out in contrast to this, allowing for real-time image acquisition and
reconstruction using handheld equipment; however, it has limitations in terms of tissue penetration and
image contrast.
Fluorescence imaging is an alternative modality that can offer real-time imaging with high contrast and res-
olution, although it has similar issues with tissue penetration (Cao et al., 2019; Huang et al., 2019; Zhang
et al., 2019a). Fluorescent imaging typically involves the administration of an exogenous probe to allow
for signal generation. Excitation of these agents through the application of light of an appropriate wave-
length causes them to fluoresce; collection of this emitted signal produces the image. This imaging modal-
ity is of great benefit for diagnosis, with preclinical applications for tumor identification and brain injury
being demonstrated (Li et al., 2020). It has also been shown to be applicable to single-cell tracking (Awasthi
et al., 2020) for studying the immune system and circulating tumor cells and has also been applied to fluo-
rescence-guided surgery (Tian et al., 2020).
When focusing on the biological applications of fluorescent probes, and imaging with these probes, there are
ideal characteristics that they should possess. They must be selective for the target, possess low toxicity for the
organism, and have excellent fluorescent properties (i.e. high photoluminescent quantum yield [PLQY], photo-
stability, tuneable emission) that allow visualization of the probe’s localization/distribution with a reasonable tis-
sue penetration depth. Recent advances in fluorescent imaging have pushed the maximum reported tissueiScience 24, 102189, March 19, 2021 ª 2021
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Figure 1. NIR-I and NIR-II optical transparency windows in some biological tissues and fluids
These plots of effective attenuation coefficient (on a log scale) versus wavelength show the quantitative relevance of
different body substances (oxygenated blood, deoxygenated blood, skin, and fatty tissue) when aiming for deep sub-skin




Reviewdepth, from 3.2 cm to 8 cm, and allowed for the whole imaging of a live rat and also the tracking of 100 mmpar-
ticles through the gastrointestinal tract of a live mouse (Dang et al., 2019).
Fluorescent probes can be small organic molecules (e.g. cyanine, rhodamine, or BODIPY), metal com-
plexes (e.g. Ir, Ru, Ln), fluorescent proteins (e.g. GFP), polymers, or nanoparticles. A key part of the fluores-
cent probe is the organic dye. Unfortunately, many organic dyes have the significant limitation that their
excitation and emission lie within the ultraviolet (UV)-visible region, outside the biological transparency
windows. In biological applications the exciting or emitted light may be absorbed by water, hemoglobin,
oxygenated hemoglobin, skin, fat, proteins, and cell structures (Hemmer et al., 2016; Zhao et al., 2018). This
hampers the use of this technique and limits its application to regions close to the surface of the sample or
patient being monitored when using light in the UV-visible range (Zhang et al., 2016). Furthermore, there is
a background signal, or autofluorescence, produced by tissues within the body when excitation wave-
lengths within the UV-visible range are used; this reduces the contrast and image quality obtained.
The near-infrared (NIR) region of the electromagnetic spectrum is seen as ideal for fluorescence imaging.
The scattering, absorption, and auto-fluorescence from tissues is greatly reduced in this region. This should
allow for improved image quality and greater tissue penetration, broadening the applications of this tech-
nique for diagnosis of disease and monitoring of treatment. The NIR region can be further separated into
NIR-I (between 650 and 950 nm) and NIR-II (between 1000 and 1400 nm), the so-called NIR biological win-
dows. It is within these windows that the interference of biological media is lowest (Figure 1).
Quantum dots (QDs) are a subset of nanoparticles and given their properties, can be used as fluorescent
NIR probes, as an alternative to organic dyes.
QDs are typically inorganic semiconductor nanoparticles, with the exception of carbon QDs, with sizes usu-
ally below 50 nm. The distinct optical properties observed in these compounds, when compared with their
bulk counterparts, are due to the existence of quantum confinement effects. The quantum confinement ef-
fects that are observed are directly influenced by the material’s composition and physical dimensions. In
bulk semiconductor materials there is a band-gap energy (Eg) that represents the difference between
the highest occupied energy state of the valence band and the lowest unoccupied state of the conduction
band. When an electron in the valence band absorbs a photon with energy equal to, or higher than Eg, it
becomes excited and transitions to the conduction band. This leaves behind an ‘‘electron hole.’’ The nega-
tively charged electron and the positively charged hole form a quasi-particle called an exciton. When the
electron relaxes back to the valence band, it annihilates the exciton andmay release energy in the form of a
photon, with energy lower than Eg (due to energy lost in the transition), in a process called radiative




ReviewThe exciton has a finite size within a crystal that is defined as the exciton Bohr radius. When the size of the
semiconductor crystal is smaller than the size of the exciton Bohr radius, quantum confinement effects
arise, the charge carriers become spatially confined, and the energy levels become discrete. Therefore,
the exciton Bohr radius defines the transition point between the different properties observed in the
bulk state and in the quantum confined state. In the latter, small variations in the size of the nanocrystals
lead to size-dependent absorption and emission profiles. The control of the particle size becomes the
handle by which the optical properties of the QD can be tuned (Buhro and Colvin, 2003).
As a consequence of these interesting characteristics, QDs have been extensively studied and have found
applications in different areas such as optoelectronic devices, biological imaging, and solar energy devices
(Jamieson et al., 2007).
QDs probes have some unique properties that make them particularly favorable for fluorescent imaging
applications. These include
 Size-modulated absorbance and emission, allowing for the production of probes made of the same
material with different optical properties for multiplexing purposes (Yu et al., 2019; Zhao et al., 2018).
 High photostability, allowing imaging for extended periods of time without loss of signal—poten-
tially favorable for fluorescence-guided surgery (Jain et al., 2008; Zhao et al., 2018).
 Large Stokes shift: this simplifies filtering out the excitation light and also allows for multicolor imag-
ing using a single excitation wavelength (Yu et al., 2019; Zhao et al., 2018).
 High brightness resulting from their large excitation cross-section, allowing for improved sensitivity,
which in turn allows for imaging at the receptor concentration level (Zhao et al., 2018).
 Despite having similar PLQYs in the UV-visible range, QDs have superior PLQYs to organic dyes in
the NIR range (Resch-Genger et al., 2008).
 Longer lifetime of the excited state, potentially allowing for the development of probes that can be
used for time-delayed microscopy to avoid the autofluorescence of cells and other moieties (Pons
et al., 2019; Resch-Genger et al., 2008).
 High-surface area-to-volume ratio that allows for efficient functionalization with other imaging
agents, creating a multimodal probe, allowing imaging of disease states at different scale lengths
and different tissue depths (Stasiuk et al., 2011).
NIR QDs are a specific class of fluorescent probes that emit in the NIR region of the spectra and stand as
one of the most promising materials used in pre-clinical setting. Their small size (up to 30 nm), excellent
PLQY (up to 45% in aqueous media), high photostability, and biocompatibility are their main advantages
over the traditional molecular dyes (Resch-Genger et al., 2008). Furthermore, the possibility to load the sur-
face of these QDs with specific targetingmotifs and therapeutic agents creates the possibility to engineer a
whole new class of theranostics with enhanced properties (Li et al., 2019c; Liu et al., 2020a; Zhao et al.,
2020). Thus, further development of QDs as NIR probes for biomedical imaging could be the key to future
success of this imaging modality.
In this review we discuss the different methodologies through which QDs are synthesized and the different
classes of materials that compose these QDs, with a focus on NIR QDs. After establishing the materials
used in these nanoparticles, we discuss the state-of-the-art in biomedical fluorescence imaging, high-
lighting the possibility for image-guided surgery with NIR QDs. In a final remark, we highlight the future
perspectives and challenges that the field still has to overcome to see the NIR QDs implemented in a clin-
ical setting.SYNTHESIS OF NIR QDS
Since the discovery of an efficient method to synthesize QDs in 1993, Cd(II) and Pb(II) have been used as the
base metal for the fluorescent core of the nanoparticles (Murray et al., 1993). Although the QDs obtained
show excellent properties and NIR emission, toxicity problems due to the leaching of heavy metals have
been a major drawback for their application in biological systems (Allocca et al., 2019; Brunetti et al., 2013).iScience 24, 102189, March 19, 2021 3
Figure 2. Overview of the synthetic methodologies used for NIR QDs
(A–D) (2A) Hot-injection: in the first step, one initial precursor is mixed with the reaction solvent and degassed under
vacuum and argon. Then, the temperature is elevated close to the nucleation temperature and the second core precursor
is injected. The core growth is performed at high temperature and the NIR QDs are synthesized; (2B) Heat-up: all of the
core precursors and reaction solvents are mixed at room temperature, and the temperature is gradually increased up to
the nucleation threshold. Core growth takes place and NIR QDs are synthesized; (2C) Microwave: similar to the heat-up
method, QD precursors and reaction solvents are mixed in a microwave vessel. The vessel is then placed in a microwave
and submitted to controlled power and temperature output for a short period of time. (2D) Hydrothermal: precursors are
mixed in water at room temperature and then added to a Teflon-lined autoclave. The system is closed and submitted to




ReviewIn recent years, the synthesis of NIR QDs has evolved toward the integration of new materials such as Ag(I),
Cu(I), and more recently carbon dots (Li and Wu, 2019a; Li et al., 2019c; Zhang et al., 2020). These present
safer alternatives to the classical QDs, while even improving upon some of the photophysical properties.
The synthetic methodologies that have been developed up to the present day focus on surface modifica-
tions as means to improve the biological compatibility and at the same time increase the fluorescent prop-
erties by shifting the emission toward longer wavelengths.
Synthetic methodologies
The main synthetic methods used in the synthesis of NIR QDs are hot-injection, heat-up, microwave, and
hydrothermal synthesis (Figure 2). They possess different advantages and are used in different circum-
stances depending on the nature of reagents, solvents, and the desired coating of the final product. In-
depth reviews on these synthetic methodologies have been conducted (Reiss et al., 2016; Tamang et al.,
2016; van Embden et al., 2015), and in this section we present a summary, for a better understanding of
the following sections.
The hot-injection method (Figure 2A) was first introduced by the works of Murray and co-workers (Murray
et al., 1993), and it remains the most common method used to synthesize a wide variety of monodisperse




Reviewthis method still suffers from some drawbacks. The high temperature of the reaction results in rapid reac-
tion rates; as such, mixing of the reagents must be efficient to produce monodisperse nanoparticles. This is
more difficult to achieve as the reaction volume increases; when the volume crosses a threshold limit the
homogeneity of the batch is less reproducible, making this method less suitable for large-scale QD produc-
tion than other methods.
The heat-up synthetic method (Figure 2B) for QDs is a single-pot reaction without an injection step. The
nucleation period in this technique is usually spread over a long period of time, and because of this
some precursors start to nucleate at different time points (van Embden et al., 2015). This leads to an
increased polydispersity in size distribution. Another major drawback of this technique is the need to
employ reagents that have similar reactivities at the desired reaction temperatures (Chen et al., 2016).
Matching the reactivity of the ligands and precursors ensures that the nucleation occurs in a short window
and generates enough nuclei. The search for a larger library of reagents and solvents is thus one of the pri-
orities for the advancement of this technique.
The microwave method (Figure 2C) makes use of electromagnetic radiation to achieve a rapid and homo-
geneous heating of the reaction. The control over the rate of heating during the synthesis offers the poten-
tial for better control over the formation of the QDs (Sinatra et al., 2017), which have been exploited to
improve monodispersity in a reproducible manner. These intriguing properties make this method a viable
alternative to hot-injection methodology with respect to the monodispersity of the QDs. Nonetheless, this
method is still in its early stages of development and the QDs obtained usually have low PLQY, hindering
their applications. The requirement for a polarizable solvent makes the direct comparison to other
methods difficult, as the aliphatic solvents used are not suitable for microwave-based synthetic procedures
(Sun et al., 2016).
The hydrothermal method (Figure 2D) refers to the use of aqueous solvents at high temperature and pres-
sure for the synthesis of QDs (Sonawane et al., 2018). The synergetic effect of these conditions leads to the
rapid formation of nuclei, resulting in monodisperse QDs that do not require post-synthesis treatments in
order to be compatible with aqueous media. The hydrothermal method is often preferred when the final
application of the synthesized QDs is biological. It is the most employed variation of aqueous synthesis
of QDs, although the drawback of this method is the weak photophysical properties of the QDs obtained.
Post-treatment with methods such as size-selective precipitation, photochemical etching, and surface
modifications are usually employed in order to improve their properties (Wei et al., 2018).
All of the techniques above represent a different method of obtaining QDs, with advantages and disadvan-
tages. Hot-injection and heat-up methods are the most used and consist of using high temperatures in or-
der to control the nucleation and growth of QDs, but the reaction conditions are difficult to precisely
control and reproducibility is hard to achieve. Hydrothermal and microwave are faster and enable a better
control of the reaction conditions, but further optimizations are still required to achieve better optical prop-
erties of the synthesized QDs.QDS materials
The methodologies described in the previous section have been used to synthesize QDs with different ma-
terials in their structure. In the next section, we discuss the most used materials in the synthesis of NIR QDs
and the properties obtained using different synthetic methodologies.
Cadmium-based NIR QDS
Cd(II)-based QDs have been the most studied and applied material for QDs. The synthesis of Cd(II)-based
QDs is one of the easiest from a synthetic point of view. The core precursors, which can vary from CdO
(Peng and Peng, 2001) to CdCl2 (Cui et al., 2018), are injected into a hot solution of the solvents and stirred
for 30 to 60min to yield NIR-emittingQDs (Figure 3). The solvent used in the synthesis has changed over the
years from predominantly phosphine-based ones (tetradecylphosphonic acid, octadecylphosphonic acid)
to fatty acids (oleic acid, 1-octadece) (Peng and Peng, 2001). This change was driven by a necessity to
adhere to a more environmentally friendly chemistry, and at the same time, fatty acids also allow for an
easier transition between crystal shapes. This change in shape allows for the appearance of higher energy
transitions in the crystal structure of the QDs, thus extending the emission toward longer wavelengths.
Cd(II)-based NIR QDs that have been published in recent years comprise CdS (d = 3.7 nm, lex = 468 nm,iScience 24, 102189, March 19, 2021 5
Figure 3. Overview of NIR Cd-based (CdTe/CdS) QDs’ optical features, synthesized via hydrothermal method
(A and B) (A) UV-visible absorption and (B) corrected PL spectra of NIR-emitting NAC-capped CdTe/CdS QDs prepared
from various reaction times (lex 400 nm). The emission peak of these QDs occurs in the first window of the NIR range, up to





Reviewlem = 730 nm), CdTe (d = 5.7 nm, lex = 576 nm, lem = 606 nm), and some alloyed compounds as well (Cui
et al., 2018; Saikia et al., 2017).
The synthetic methodologies for Cd(II)-based QDs can yield organic-phase QDs and also water-soluble
QDs that are biologically compatible. One route to the synthesis of water-soluble CdS NIR QDs (d =
3.7 nm, lex = 468 nm, lem = 730 nm) has been described by Cui and co-workers (Cui et al., 2018) using
CdCl2 in a solution of BSA. Addition of L-cysteine provides the sulfur source and reacting at 80
C for
30 min yields CdS QDs that are water soluble due to the BSA matrix. These QDs had a first excitonic
peak at 450 nm, allowing the authors to excite the QDs with an emission source at 468 nm, obtaining
an emission in the first NIR region, centered at 730 nm. The resulting high-water solubility of thesematerials
allows for the direct application of these QDs to cell imaging.
In order to optimize the optical properties of established QDs, doping of their matrix with chosen atoms is
becoming a fast-growing research field. This can produce a blue or red shift in the emission maximum, alter
the absorbance profile, or increase the PLQY of the QDs. These changes are achieved by modifying the
semiconductor properties of the material, including the energy band-gap value. CdSe compounds usually
have emissions in the visible range but doping of certain atoms, such as silver, gives rise to more sub-band-
gap states in the crystalline structure (Zhao et al., 2019). This phenomenon ultimately introduces more ab-
sorption peaks and extends the absorption edges of CdSe QDs into the infrared regime.
A recent study shows the production of ternary CdS1-xAgx QDs (d= 15 nm, lem= 700–800 nm, PLQY= 36%), in a
biosynthetic method using Escherichia coli bacteria (Órdenes-Aenishanslins et al., 2020). This method takes
advantage of the E. coli enzymatic activity, producing H2S in the presence of cysteine. This volatile compound
is then secreted to the surrounding area and reacts withCd(II) ions to formCdSQDs. In addition, by the addition
of different concentrations of AgNO3, the Ag ions replace some of the Cd to form ternary CdS1-xAgx QDs that
emit in the NIR-I window with reported PLQY of 36%. This simple and environmentally friendly method opens
the possibility to use cells to produceQDs. Other studies for the biosynthesis of Cd-basedQDs in different bac-
terial cells have been reported (Gallardo Benavente et al., 2019; Lin et al., 2020; Sur et al., 2019).
Other groups have reported ternary Cd-based QDs with different compositions. The synthesis of CdHgTe
ternary QDs capped with mercaptopropionic acid (MPA) (d = 2.5–4.2 nm, lem = 730 nm) was achieved using
the hydrothermal method with CdCl2, HgCl2, Na2TeO3, and MPA (Jagtap et al., 2016). By tuning the reac-
tion time over 2–30 min, the resulting QDs size can be controlled, ranging from 2.5 to 4.2 nm and a corre-
sponding emission in the NIR region, ranging from 650–855 nm.
Cd(II) was one of the first elements to be used in the synthesis of QDs, and the synthetic methodologies




Revieware reports of Cd-based QDs synthesized with different precursors, through variations of different method-
ologies, emitting in the NIR-I range. The best QDs are obtained via the hot-injection and heat-up methods,
with PLQY approaching near unity in organic solvents and with sub-10 nm sizes (Elibol, 2020). After surface
functionalization or through hydrothermal synthesis, Cd(II) QDs can be dispersed in aqueous media and be
suitable for biological applications. Nonetheless, despite the large amount of research with this material
for its use in biomedical applications, the toxicity associated with this heavy metal is a major concern.
Copper-based NIR QDS
The use of Cu(I) as a metal for the cores of NIR QDs has increased in the past years, both as a dopant and as
a component of ternary QDs. The incorporation of copper in this manner results in a broadened emission
profile, alongside a bathochromic shift in the emission maxima.
The most represented examples of QDs that incorporate Cu(I) into the core are Cu:InP and CuInS2 QDs.
Although InP QDs usually have an emission range in the visible region (d = 2–10 nm, lem = 450–625 nm),
Cu:InP QDs have a greatly extended emission range, while maintaining the size of the particles (d = 2–
10 nm, lem = 580–1110 nm) (Clarke et al., 2019; Li and Wu, 2019a; Reiss et al., 2016). This doping has other
beneficial effects on the optical properties of these QDs: a larger Stokes shift, longer emission lifetimes,
emission maxima in the NIR range, and improved chemical stability (Pradhan et al., 2017).
Recently, Kays and co-workers studied the influence of ZnS shelling (d = 4.5–10 nm, lem = 682 nm) and Zn
doping of CuInS2 QDs (d = 3.5 nm, lem = 822 nm) on their toxicity. The synthesis followed a hot-injection
method, by adding the sulfur precursor hexamethyldisilathiane into a solution of Cu(II) and In(III) salts with
TOP and ODE as solvents (Kays et al., 2020). Shelling the bare CuInS2 cores with ZnS reduced the wave-
length of the emission maxima from 822 to 681 nm, whereas the diameter increased from 3.5 to 4.5 nm.
Zinc doping showed just a slight blue shift in the emission maxima from 822 to 808 nm with no change
in diameter. The results showed a reduction of toxicity in mice and in the human liver cancer cell line
HepG2. Using a moderate in vivo dose of 15 mg kg1, the non-shelled particles induce severe hepatotox-
icity and splenotoxicity, whereas in vitro tests demonstrate cell viability <20% with doses greater than
0.2 mg mL1. In contrast, the ZnS-shelled CuInS2 QDs do not reduce the cell viability at this concentration.
This demonstrates the fact that although CuInS2 QDs can be considered for NIR imaging, appropriate shel-
ling methods must be developed in order to avoid the leaching of ions from the core.
Xia and co-workers have also synthesized CuInS2/ZnS QDs (d = 3–8 nm lem = 750–1100 nm) that can emit in the
NIR windows (Xia et al., 2017). The synthetic approach aimed at obtaining wurtzite CuInS2 structures, contrary to
the chalcopyrite that are usually obtained throughdirectmethods. The authors hypothesized that this hexagonal
wurtzite structurewould allowCuInS2QDs to emit at higher wavelengths. The authors first synthesizedCuS struc-
tures using a hot-injection method and then performed a cation-exchange, replacing Cu(I) ions with In(III), by
slowly adding In(Ac)3 precursor. Following shelling, the resulting CuInS2/ZnS QDs showed emission peaks at
longer wavelengths, from 750–1100 nm depending on the size of the crystal (3–8 nm). CuInS2/ZnS QDs synthe-
sized in this way (d = 4.7G 0.5, lem = 820 nm) had a PLQY of 75% in chloroform.
Kubicek-Sutherland and co-workers also described the synthesis of alloyed Cu(I)-based NIR QDs
(Kubicek-Sutherland et al., 2020). The CuInSeS/ZnS QDs (d = 7–10 nm, lem = 550–1200 nm, PLQY >
95%) were synthesized by optimizing a previously described hot-injection method, producing sub-
10 nm QDs with promising fluorescent properties in the NIR-I biological window, by changing the Se/S
ratio. The cytotoxicity of the QDs was also tested on mouse fibroblast cells and shown to be less toxic
than commercially available CdSe/ZnS and InP/ZnS QDs. The difference in toxicity was visible after
6 days of incubation of 100 mg mL1 QDs with the mouse fibroblast L929 (CCL-1) cell line. Although
both the Cd(II) and In(III) QDs reduced the viability of the cells to below 50%, the Cu(I) QDs had almost
no effect on the viability of the studied cells. The tissue penetration was also evaluated, with the QDs
fluorescence being detected through 32 mm of a hemoglobin solution and through 3.5 mm of turkey
meat (tissue phantom). These results highlight once more the favorable optical and biological properties
of Cu(I) QDs for biomedical applications.
These results show that incorporating Cu(I) into QDs with an In-based core can greatly alter their optical
properties, making them suitable for NIR imaging without compromising on the already established size
and PLQY. Nonetheless, the incorporation of Cu(I) does not solve the toxicity issues that many QDsiScience 24, 102189, March 19, 2021 7
Figure 4. NIR-fluorescence imaging of mouse brain before and after treatment with PbS QDs
(A–C) (A) Experimental setup for NIR fluorescence imaging of cerebral blood vessels. An anesthetized mouse was
administered QD1100 (PbS QDs) in a caudal vein. An optical laser (785 nm wavelength) was used as an excitation light
source, and NIR fluorescence was detected with an InGaAs camera. (B) Imaging of a mouse head. Bright field image (left),
NIR fluorescence image without QD administration (middle), and the NIR fluorescence image with QD administration
(right). Scale bar: 1 mm. (C) NIR fluorescence images of cerebral blood vessels. Upper: fluorescence image after scalp





Reviewshow, and careful control of the surface chemistry is required before these QDs can be safely used in bio-
logical applications.
Lead-based NIR QDS
The first report of the colloidal synthesis of Pb-based NIR QDs was published by Murray and co-workers in
2001 (Murray et al., 2001). This work described the synthesis of PbSeQDs (d= 3–9 nm, lem= 1200–2200 nm),
using the hot-injection method of TOP-Se and Pb(II) oleate precursors into a solvent solution at 150C. This
resulted in a series of QDs with sizes ranging from 3.5 to 15 nm by tuning the reaction temperature from
90C to 220C. This wide range of sizes is reflected in the optical properties of the QDs, with the smallest
QDs presenting an exciton absorption at 1200 nm and the largest particles at 2200 nm, therefore posi-
tioning all of them in the second NIR window.
Given their excellent emission profile in the NIR window, Pb-based QDs have been synthesized with the
goal of developing functional probes for in vivo imaging. NIR-emitting PbS QDs (d = 3–9 nm, lem =
1100 nm, PLQY = 8%) have been used for in vivo fluorescence imaging of cerebral blood vessels in mouse
(Imamura et al., 2016). The synthesis followed a hot-injectionmethodology, where the reaction of PbCl2 and
hexadimethyldisilathiane in a mixture of oleylamine and oleic acid resulted in the formation of PbS QDs
coated with oleylamine. The surface was modified with mercaptoundecanoic acid after synthesis, to grant
dispersibility in aqueous phase. These PbS QDs present an emission peak at 1100 nm with a relatively low
PLQY of 8% in water. Despite this, the use of these QDs allowed for the non-invasive imaging of septic en-
cephalopathy in mice (Figure 4), and it highlights the usefulness of these nanomaterials in imaging of
different vascular systems.
Although their tuneable emission across the NIR range makes PbS QDs very promising, they are prone to
surface oxidation and suffer from a significant reduction in PLQY upon phase transfer into water (Welsher
et al., 2009). Coating the PbS core in a shell made up of another material is one route to prevent this, allow-
ing this exciting material to be used for biomedical applications. Zhang et al. demonstrated a CdS shelling
technique; following synthesis of the PbS cores in oleylamine at high temperatures (120C–160C), a CdS
shell was introduced via cation exchange using CdO, oleic acid, and octadecene at 100C to yield a shell




Reviewfor their dispersion in water. The overall diameter of the QDs was slightly increased by this process
(increasing from 5.4 nm to 6.9 nm), although less than would be expected for such a shell thickness. This
shelling process was accompanied by a slight blue shift in the emission maxima (1725 nm–1650 nm), which
was attributed to the cation exchange reducing the size of the PbS core. An increase in PLQY (from 0.33%–
3.3% to 2.2%–22%) in water was also observed. The shelling procedure was also demonstrated to improve
the photostability under laser irradiation over 2 h and the stability of the QD emission when incubated in
PBS over 28 days. In addition to passivating the core surface, the difference in bandgap between the CdS
shell and PbS core ensures that the electrons and holes are localized in the PbS core, thus resulting in a
core-shell QD that retains the optical properties of the PbS core (Kim et al., 2015).
In a similar way to Cd(II), Pb(II)-basedQDs use the hot-injection and heat-upmethods in order to synthesize
materials that would emit in the NIR range. One of the advantages of using Pb(II) as the core element is the
emission in the second window of the NIR (1000–1400 nm), whereas Cd(II) materials generally emit in the
first window (700–950 nm). This would benefit imaging experiments, as the tissue autofluorescence and wa-
ter absorption is minimized. In terms of PLQY, Pb(II)-based QDs have a tendency to show lower values (up
to 20%) when compared with Cd(II)-based QDs (up to 45%), using the same hot-injection method, which
balances the higher emission wavelength verified before. Despite these promising optical properties
and several years of research invested in developing these Pb(II) and Cd(II) NIR QDs, the toxic nature of
the precursors greatly hinders their clinical translation and asks for safer, biocompatible alternatives.
Silver-based NIR QDS
As seen by the previously described QDs materials, Cd and Pb QDs possess excellent optical properties,
but the heavy-metal composition limits their application in imaging biological systems. Over the past few
years, the interest surrounding silver chalcogenide (Ag2X, X = S, Se, Te) QDs has grown due in part to their
NIR emission, low toxicity, simple synthesis, and good core stability.
Ag2S QDs were first synthesized in 2004 (Liu et al., 2004), with a size distribution of 5.9 G 1.65 nm and an
absorption maxima at 330 nm, without mentioning their fluorescent properties. In 2010, Wang and co-
workers were the first to address the NIR emission of Ag2S QDs through their synthesis from a single source
precursor using the heat-up method previously described (Du et al., 2010). The silver precursor used was
((C2H5)2NCS2)Ag, with additional oleic acid and oleylamine ligands in octadecene at 200
C. The as-ob-
tained Ag2S QDs with a size of 10.2 G 0.4 nm exhibited NIR emission centered at 1058 nm, with a narrow
full width at half maxima (FWHM) value of 21 nm. This single-source precursor synthesis was adopted by
other researchers to synthesize PEG-Ag2S QDs (dhydrodynamic = 26.8 nm, lex = 808 nm, lem = 1100 nm,
PLQY = 15.5%) (Hong et al., 2012; Zhang et al., 2014).
In 2012, Zhang and co-workers also addressed the properties of Ag2S QDs and their cytotoxic effects on
cells (Zhang et al., 2012). The synthesized Ag2S QDs (d = 5-10 nm, lem = 1000–1320 nm, PLQY = 15.5%)
were coated with PEG-DHLA and tested in breast cancer cell line (MDA-MB-468) and human glioblastoma
cell line (U87 MG) for targeting experiments and in mouse fibroblast cell line (L929) for cytotoxic experi-
ments. For the targeting experiment, the QDs were functionalized with proteins recognized by the
epidermal growth factor receptor (EGFR), which has a higher level of expression in MDA-MB-468 cells
than in U87MG cells. The results showed a good targeting ability toward theMDA-MB-468 cells, exhibiting
high NIR emission intensities, unlike in the U87 MG cells. This demonstrates the specificity of the QDs and
the response in terms of NIR emission. In the cytotoxicity studies, Ag2S QDs demonstrated negligible
toxicity in terms of cell proliferation, apoptosis and necrosis, reactive oxygen species’ production, and
DNA damage in L929 cells. This comprehensive study shows the potential of Ag(I)-based QDs for biomed-
ical imaging and provides a strong biological argument for its future development and optimization.
Ag2TeQDs have the same excellent properties and biocompatibility as Ag2S and Ag2SeQDs and addition-
ally have a narrower direct bandgap of 0.06 eV (compared to 0.93 and 0.15 of Ag2S and Ag2Se, respectively)
(Kershaw et al., 2013). This narrow bandgap will shift the optical properties to lower energies, increasing
their optical efficiency and extending the emission toward longer wavelengths (Butson et al., 2019).
Zhang and co-workers demonstrated the hot-injection synthesis of Ag2Te QDs (Zhang et al., 2020); starting
from a mixture of Ag(OAc) and 1-dodecanethiol at 120C, injection of tributylphosphine-Te rapidly yielded
Ag2Te QDs within minutes. These were subsequently coated with an Ag2S shell by addition of furtheriScience 24, 102189, March 19, 2021 9
Figure 5. Optical and physical profiles of Ag-based NIR QDs
Panel 1: (A) NIR absorption spectrum of as-obtained Ag2S QDs; the inset is a photograph of Ag2S dispersed in cyclohexane. (B) NIR fluorescence emission
spectrum of Ag2S QDs at room temperature under lex = 785 nm. Adapted with permission from (Du et al., 2010). Copyright ª 2010, American Chemical
Society.
Panel 2: Synthetic procedure of Ag2Te@Ag2S core–shell QDs. TEM images of (B) Ag2Te and (D) Ag2Te@Ag2S QDs. Size distributions of (C) Ag2Te and (E)




ReviewAg(OAc) and oleylamine-S (Figure 5, Panel 2a). The shelling process increased the diameter of the QDs
from 4.06 G 0.16 nm to 4.89 G 0.10 nm (Figure 5, Panel 2c,e). Although both the Ag2Te and Ag2Te/
Ag2S QDs had emission maxima at 1300 nm, the Ag2Te/Ag2S QDs had a 3.2-fold greater photolumines-
cence intensity, with a PLQY of 4.3%. The addition of additional Ag precursors, which are readily adsorbed
in the Ag2Te surface, in the core growth stage causes an increase in the size of the core (d(Ag2Te) = 4.90G
1.06 nm, d(Ag2Te/Ag2S) = 5.71 G 0.11 nm) and a corresponding redshift in the fluorescent emission max-
ima from 1300 nm to 1524 nm (1560 nm upon shelling with Ag2S). This is within the NIR-IIb region (1500–
1700 nm), which is exciting for its reduced absorbance and potential for high spatial resolution in vivo
imaging.
When analyzing the properties of Ag-based QDs, they are very on par with other well-developed materials
such as Cd(II) or Pb(II). The increased size dispersion (from 5–30 nm) is more noticeable in Ag-based QDs,
given the more generalized use of hydrothermal methods for their synthesis. Nonetheless, the emission
range is comparable to the Pb(I) QDs, with well-reported values in the second window of the NIR range,
with known advantages in imaging. PLQY values up to 23% have been reported, which are on the same level
as Pb(II) QDs, just below Cd(II) QDs. The big advantage that Ag-based NIR QDs have over the other re-
ported materials is their high biocompatibility, even though, technically, Ag is considered a heavy metal
(Aydemir et al., 2020). There is still room for improvement with regard to the optical properties and func-
tionalization of the surface, but a translation to clinical applications is on the horizon.
Carbon-based NIR QDS
Carbon QDs (CQDs) have caught the interest of the community after their first synthesis in 2006 during the
purification of single-walled carbon nanotubes (Sun et al., 2006). The excellent biological compatibility and
low toxicity, coupled with good optical properties and NIR fluorescence, are some of the arguments in
favor of their use in biomedical imaging.
There are fundamentally two synthetic approaches for the synthesis of CQDs: top-down and bottom-up. As
their names imply, the top-down approach utilizes large carbon precursors, such as nanodiamonds, carbon
nanotubes, or carbon fibers and transforms them into smaller particles by the use of physical or chemical
processes. These can be laser ablation or oxidation with strong acids or through electrochemical oxidation.




Reviewsolvothermal or through microwave synthesis. A limitation to the bottom-up synthetic methods is that they
generally produce blue- or green-emitting QDs. To increase the relevance of CQDs produced in this
manner, there is an ongoing search for different precursors that can be used to produce more relevant,
NIR-emitting, CQDs. Despite being a recently developed class of QDs, CQDs have already been applied
to several systems and therapies, such as photothermal therapy, photodynamic therapy, and chemical and
biological sensing (Ge et al., 2014; Nair et al., 2014; Pang et al., 2020).
CQDs have been synthesized using the microwave synthetic method, through the pyrolysis of glycerine in
the presence of polydopamine (Bai et al., 2018). The presence of dopamine allows for a further passivation
of the surface of the CQDs and additional nucleation sites provided by the phenolic group. The synthesis is
performed in just 5 min, and the PLQY of these CQDs is 5%. The low PLQY is obviously a limitation for their
application, but the extreme fast synthesis and biocompatibility supports the investment in further devel-
oping this method.
Li and co-workers synthesized NIR-emitting CQDs by combining the solvothermal method and microwave
methods (Li et al., 2019b). In a first step, red-emitting CQDs are synthesized by the solvothermal route by
mixing citric acid and urea in dimethylformamide (DMF) in an autoclave at 160C for 6 h. In a second step,
the synthesized CQDs were then mixed with DMF and heated by microwave irradiation at 100C for 70 min
at atmospheric pressure. Here, the microwave synthesis acts as an exfoliating method for the graphene-
layered red-CQDs. The choice of solvent is important as the DMF, with its electron-accepting carbonyl
group, can interact with the carbon skeleton on the pre-formed CQDs and disrupt the layer-staking pro-
cess. The results are NIR-emitting CQDs with emission peaks at 770 nm and with PLQY of 11%. These nano-
particles show further thermally induced electron transitions that allow for the occurrence of upconverting
photoluminescence, without the need to use pulsed laser beams. This allows for a continuous excitation
(808 nm) of the CQDs and introduces them as viable in vivo NIR probes.
Although carbon is an interesting element to develop probes, given its excellent biological compatibility,
the synthesis of CQDs is still in an early stage. The different methods that have been used still need to be
optimized, because the emission peaks obtained through hydrothermal and microwave methods barely
occur in the NIR-I range, and the PLQYs obtained through these methods generally are lower in compar-
ison to the other materials.
BIOMEDICAL IMAGING APPLICATIONS
The combination of the high resolution and rapid image acquisition of fluorescent imaging, the increased
tissue penetration of NIR light, and the optical properties of QDs, yields the opportunity for developing
imaging agents that can be used for unique applications. The high photostability of QDs lends itself to ap-
plications in which repeated imaging is necessary—for example, tracking of individual cells or image-
guided surgery. The nature of nanoparticle surface chemistry allows for the addition of repeated targeting
agents to improve affinity, or of secondary ligands (such as PEG chains) to tune the biodistribution, or to
incorporate additional modalities to allow for multimodal imaging. The large Stokes shift of QDs also al-
lows for multiplex imaging—imaging of multiple targets with the same excitation wavelength, by moni-
toring different emission wavelengths—that can allow for imaging multiple different targets, either for
simultaneous imaging of different tissue types or for validation/increased specificity of a cell type.
Non-specific targeting
QDs have been applied to various biomedical imaging applications, with and without specific targeting
motifs being incorporated.
Pons et al. used ZnCuInSe/ZnS QDs (d = 3–4 nm, d(hydrodynamic) = 9 nm, lem = 800 nm, PLQY = 20%–30%)
to track individual cells in vivo through time-gated imaging in the NIR window. By preparing QDs with a
fluorescence lifetime (150–300 ns) greater than the observed lifetime of the autofluorescence, the authors
were able to collect only the signal from theQDs by waiting for the background signal to decay. Calibration
of this delay time (20 ns) in a QD-labeled red blood cell model resulted in rejection of 99% of autofluores-
cence but retention of 60% of the QD fluorescent signal. The QD-labeled red blood cells were imaged in
the blood vessels in the ear of amouse; by tracking individual cells the velocity in the blood vessels could be
measured as being 200–300 mm s1. Applying the same imaging technique to lymphoma (murine reticulum
cell sarcoma) cells in larger blood vessels gave a velocity of approximately 1000 mm s1 (Pons et al., 2019).iScience 24, 102189, March 19, 2021 11
Figure 6. Unspecific targeting of NIR QDs in the imaging of cancer cells and vasculature
Panel 1: In vivo tracking of cancer cells. Adapted with permission from (Awasthi et al., 2020). Copyright ª 2020, Royal Society of Chemistry.
Panel 2: Femoral artery and vein resolution with separation of 320 mm. Adapted with permission from (Zhang et al., 2018). Copyright ª 2019, American
Chemical Society.
Panel 3: Long blood-circulating Ag2S QDs allow for imaging of femoral artery of width 377 mm. Adapted with permission from (Awasthi et al., 2020).




ReviewAwasthi et al. used Ag2SQDs to track metastatic tumor cells in the blood stream. They incubated A549 can-
cer cells (50,000 cells ml1) with PEG-PATU coated Ag2S QDs (100 mM) for 4 h, resulting in an average of
0.296 ng Ag2S per cell. These cells were then intravenously administered into a mouse and followed by
NIR-II emission over 24 h. The fluorescence signal initially appeared in the liver but redistributed across
the whole body over the 24-h period (Figure 6, Panel 1a). In contrast, when the same dose of PEG-PATU
Ag2S QDs (14.78 mg mL
1 Ag2S) was administered in healthy controls, the emission remained confined
within the liver throughout the experiment (Figure 6, Panel 1b), suggesting that the in vivo behavior of
the cancer cells could be imaged using this technique (Awasthi et al., 2020).
Awasthi et al. also explored the use of Ag2S QDs for angiography. By conjugating larger PEG chains
(PEG1000) to the Ag2S QDs they sought to prolong their blood circulation in vivo. When applied via intra-
venous injection into a mouse (injected dose = 200 mg Ag2S) the vascular system of the mouse could be
visualized through the NIR-II emission. This yielded high spatial resolution images (femoral artery diameter
of 377 mm observed) in ‘‘real time’’ (Awasthi et al., 2020).
Varying the surface coating in this way is an important tool for optimizing the performance of QD-based
imaging agents. Changing the coating agent allows for the use of optimized materials for different appli-
cations—changing the size, charge, and other targeting properties without significantly altering the optical
properties.
Zhang et al. used PbS/CdS QDs (lex = 808 nm, lem = 1650 nm, injected dose = 400 mg PbS/CdS) coated in a
branched PEG layer to image blood flow in mouse vasculatures. The QDs had a long blood circulation half-life
of7handcouldbe imagedat60 framesper secondthrough theskinwithanexposure timeof2–5ms.Thisallowed




Reviewused toproduce a 3D confocal image ofMC38 tumor vasculature (imaging depth 1.2mm) in livemice, with accu-
mulation attributed to the enhanced permeation and retention (EPR) effect. The accumulation reached a peak at
24 h post-injection, with a tumor to normal tissue ratio of 32.6 (Zhang et al., 2018). The PbS/CdSQDswere shown
to be primarily excreted with the feces; with 76% of injectedQDs being excreted within 28 days. These excreted
QDs were shown to be intact via TEM, and no obvious toxicity was seen in vivo. However, a significant portion of
the injectedQDs remainedwithin themice after 1month; 0.7%being retained in the liver, spleen, lungs, kidneys,
stomach, and gut, with the rest being distributed throughout the body, including in the bones, skin, muscle, and
brain.Given the toxic natureof the componentmaterials (Pb(II) andCd(II)), this long retention isworrying andmay
hamper future applications despite the apparent high stability.
These two separate studies on the use of NIR QDs for imaging of blood vessels in mice both found similar
limits to the lateral resolution—377 mm (Awasthi et al., 2020) and 320 mm (Zhang et al., 2018). This is a fairly
high resolution but does not yet approach the limits possible for fluorescence imaging through, for
example, confocal microscopy. This is likely due to the inherent constraints of imaging inside an animal
versus a single slice of cells but is something that future developments may improve upon.
These examples serve to demonstrate the high spatial and temporal resolution obtainable with NIR QDs.
This high-quality imaging data can be acquired rapidly and repeatedly, enabling a greater understanding
of rapid processes in vivo (Pons et al., 2019). The ability to track cell populations as they are distributed can
be used to further understand metastatic cancer (Awasthi et al., 2020; Pons et al., 2019), bacterial infections
(Wang et al., 2020), and immune responses (Yu et al., 2019; Yuan et al., 2020), potentially opening new av-
enues of therapy.Specific targeting
There are a number of approaches that can be taken to target QDs specifically to disease states. The QDs
can have targeting agents added to the surface; this can take the form of small molecules (Ge et al., 2019),
peptides (Li et al., 2020; Tang et al., 2015), proteins (Le et al., 2020; Sarkar et al., 2020), or antibodies (Yu
et al., 2019). The QDs can also be incorporated into larger systems (Zhang et al., 2019b), such as cell ves-
icles, that have targeting agents on the surface and act as carriers of the QDs.
Ge et al. used the increased glucose consumption of tumors to target their Ag2Se QDs. By reacting the
pendant carboxylic acids of the coating ligands with glucosamine they added glucosemolecules to the sur-
face of theQDs. These showed increased uptake inMCF-7 cells compared with the non-conjugatedQDs as
assessed by flow cytometry (93.9% of cells labeled versus 4.2%). In vivo the glucose-coated QDs showed
tumor accumulation in 2 h post-injection and were still detectable after 7 days (Ge et al., 2019). In tumor
bearing mice, Ag2Se QD fluorescence was still observable 7 days post-injection in the kidneys, and in
nude mice, Ag could be detected in both the heart (5.41 G 4.8 mg g1) and kidneys (113.73 G 19.00 mg
kg1) 7 days after injection of the glucose-coated Ag2Se QDs (150 mg kg
1 injected dose, 10 times the
dose used for imaging experiments), although no significant difference in blood biochemistry was
observed over this period.
Tang et al. targeted the avb3 integrin using a cyclic pentapeptide, cRGDfK, conjugated to the surface of
small Ag2S QDs (lem = 820 nm, d = 6.12G 1.09 nm, PLQY = 14.1%). This resulted in a probe with an average
of 5 peptides per QD; the affinity of this conjugate for avb3 integrin receptor (2.74G 0.94 nM) was shown to
be comparable to the peptide on its own (1.42 G 0.38 nM) and superior to a small molecule analogue
(4.29 G 0.56 nM). When applied in vitro the cRGDfK-Ag2S QDs exhibited intracellular fluorescence within
1 h in mouse breast cancer cell lines (4T1luc), which increased throughout the 24 h of experimental time.
The non-conjugated QDs showed negligible internalization in this time frame. Similar internalization pat-
terns were seen in A549 human lung adenocarcinoma epithelial cells. In vivo the targeted QDs showed up-
take in the tumors after 1 h, again with maximal contrast after 24 h. Based on the in vivo imaging results, the
authors concluded that the small hydrodynamic size of theseQDs results in a similar biodistribution to small
organic molecules. However, ex vivo analysis of the organs reveals significant uptake in both the kidneys
and liver alongside the tumors, with lower uptake in other organs and tissues. This is to be expected as
these are the primary excretion routes, but this highlights the importance of validating the observed in vivo
results further. Tang et al. also highlight the photostability of QDs, with no change in emission intensity
observed over 24 h with irradiation from a tungsten lamp or over 30 days in a refrigerator at 4C and multi-




ReviewLi et al. developed Ag2S QDs for imaging of traumatic brain injury (TBI). They paired the Ag2S QDs (lem =
1050 nm) with an organic dye, A1094, that has absorption overlap with QDs emission (1094 nm), forming a
Förster resonance energy transfer (FRET) pair that results in a quenched emission. However, in the pres-
ence of peroxynitrite (ONOO) this dye is oxidized reducing its absorbance at this wavelength and allow-
ing the QD emission to be observed. The pair form a ‘‘turn ON’’ sensor for ONOO that was exploited in
this work to offer a highly specific and sensitive imaging probe for this biomarker of TBI. The authors
comparedQDs coated with VCAM1 binding peptide (V@Ag2S, targeted, always on), A1094 FRET quencher
(A@Ag2S, non-targeted, activatable), and a combination of both (V&A@Ag2S, targeted and activatable) in a
TBI mouse model. They also compared these results with the V&A@Ag2S probe in a healthy mouse. The
results show that without the targeting agent or TBI theQDs do not show any significant uptake in the brain.
However, with the targeting agent there is widespread uptake within the brain resulting in a large back-
ground signal and the site of injury being difficult to detect. When imaged with the targeted, activatable
probe, the injury is apparent, as there is no background signal from the non-injured regions of the brain
(Figure 8, Panel 1) (Li et al., 2020).
Through the use of HgxCd1-xSe/CdyZn1-yS QDs with similar emission profiles (600–700 nm), but different sizes
(9.2–17.4 nm hydrodynamic radius), Le et al. delineated the effect of size on the signal-to-noise ratio obtained
in three different biological models: live cells, fixed cells, and neuronal synapses. Throughout this work they
had to contend with a significant difference in brightness observed for the different-sized nanoparticles due to
different absorbance and blinking properties. Despite this, the authors were able to show that the nanoparticle
samples thatwere smaller than 15 nmhad superior signal-to-noise ratio due to reduced non-specific uptake, and
in the case of the sterically crowded environment of the neuronal synapses only the smallest nanoparticles were
able to effectively image the region of interest effectively (Le et al., 2020).
In another study, the same group developed three domain (core)shell/shell (HgxCd1-xSe)HgyCd1-yS/
CdzZn1-zS QDs with emission from 630–1360 nm. This range of emission wavelengths was obtained without
varying NP size (6 nm) but instead by varying the core composition, with Hg/Cd ratios of 0–0.31. These QDs
had similar brightness and PLQY and were again applied to imaging in a variety of biological models. When
applied to single QD imaging, the NIR-emitting QDs performed significantly better due to the reduced au-
tofluorescence. Sarkar et al. reported that in this region the autofluorescence was so low as to be indistin-
guishable from background. This resulted in signal-to-noise ratios (SNR) of 55, whereas for the QDs in the
visible range the ratio was 1.6 due to a higher background signal. A similar result was seen when imaging
RNA, resulting in an approximately 10-fold improved SNR for the NIR-emitting QD samples compared with
the visible region emitting samples. When studying fixed mouse adipose tissues, the autofluorescence was
found to be much higher. The visible emitting QDs were not distinguishable from this autofluorescence,
but the QDs emitting at 950 and 1130 nm were able to be imaged (SNR ratios of 23 and 29, respectively)
allowing for the imaging of alpha tubulin with these probes (Sarkar et al., 2020).
The large Stokes shift of QDs, combined with a broad absorbance spectra, can allow for the design of multi-
plexing systems in which a single excitation laser can be used to excite two different QD probes. Yu et al.
used this property to image myeloid derived suppressor cells (MDSCs) in order to gain further understand-
ing into immune checkpoint blockades to help develop immunotherapy. MDSCs express both CD11b and
Gr-1; the authors proposed two-color imaging of both antigens simultaneously to allow for specific imag-
ing of the cells that express both through colocalization of the signal. Yu et al. prepared two different PbS/
CdS QDs probes that emit light in the NIR-II window when excited by light at 808 nm: NIR-IIa (d = 4.7 nm,
lem = 1100 nm, PLQY = 6.5%) was conjugated to the CD11b-targeting monoclonal antibody (d(DLS) =
41.7 G 0.6 nm upon conjugation, z = 3.7 G 0.1 eV) and NIR-IIb (d = 6.8 G 0 0.4 nm, lem = 1600 nm,
PLQY = 2.3%) conjugated to a Gr-1 monoclonal antibody (d(DLS) = 44.5 G 0.6 nm upon conjugation,
z=2.8G 0.1 eV). Two-color imaging of amouse with a SCC7 xenograft showed an increased fluorescence
in the tumor, spleen, and lungs for over 72 h (Figure 7)—the control (PbS/CdS QDs with a goat antirabbit
IgG antibody conjugated to it) accumulated in the tumor initially before clearing, and no signal was seen in
the spleen or lungs after 48 h. The presence of MDSCs in the lungs was confirmed by histological analysis
and flow cytometry and the relative abundancy compared with the spleen and tumor validated in relation to
the fluorescence. No significant cytotoxicity or in vivo toxicity was detected using this probe. This work
shows the viability of multiplex imaging within the NIR-II window using QDs and also acts as a demonstra-
tion of the use of this technique for targeting a specific subset of cells in vivo through the use of comple-
mentary antibodies (Yu et al., 2019).14 iScience 24, 102189, March 19, 2021
Figure 7. In vivo non-invasive two-color fluorescence imaging of mouse possessing SCC7 xenograft in the NIR-II
window
The mouse was intravenously injected with the mixture of CD11b@NIR-IIa QDs and Gr-1@NIR-IIb QDs nanoprobes and
was imaged at different time points with 808 nm excitation and 980 nm LP plus 1200 nm SP emission filters for NIR-IIa
channel and 980 nm LP plus 1500 nm LP emission filters for NIR-IIb channel. Scale bar: 10 mm. Imaging experiment
parameters: 13 magnification objective, 808 nm laser, laser power: 20 mW/cm2, exposure time: 200 ms. Adapted with




ReviewZhang et al. compared the effect of different coatings on the tumor uptake of Ag2Te QDs. Three samples
were prepared: PLGA polymer-coated QDs (PQDs), PLGA polymer-coated QDs that had been further
coated with PEG (a typical ‘‘stealth’’ coating) (PPQDs), and PLGA polymer-coated QDs contained within
a cell vesicle (CV) by extrusion (CPQDs). The CVs were prepared from the cell membranes of 4T1 (mammary
breast cancer) cells; these CVs contained a greater CD47, EpCAM, TF-antigen, and E-cadherin protein con-
tent than the whole cell lysates, with similar content in both the CVs and CPQDs. The CPQD uptake by mac-
rophages after 4 h was shown to be substantially lower than the non-coated PQDs and slightly less than the
traditional PPQDs. The CPQDs were also found to have extended blood retention when injected intrave-
nously into a mouse, with a blood half-life of 7.4 h (1.6 h for PQDs, 6.0 h for PPQDs). Whole-body NIR II fluo-
rescence images of mice with 4T1 tumors that had been injected with either PQDs, PPQDs, or CPQDs over
48 h showed the two ‘‘stealth’’-coating QDs had increasing fluorescent intensity within the tumor over time
(maximum 24 h post injection), whereas the PQDs showed no uptake (Figure 8, Panel 2a). The CPQDs
showed the highest fluorescent intensity in the tumors, with tumor/tissue ratio reaching a maximum of
13.3 at 24 h post-injection (Figure 8, Panel 2b). This shows that coating in the membrane of 4T1 cells can
be used to target 4T1 tumors as expected, as many of the proteins are ‘‘self-targeting.’’ However, the ques-
tion of whether this can be applied as a generic tumor targeting coating remains, and this may be where the
simple PEG coating remains a more effective route to production of generic contrast agents rather than
bespoke (Zhang et al., 2019b).iScience 24, 102189, March 19, 2021 15
Figure 8. Targeting ability of Ag-based NIR QDs dependent on the surface coating
Panel 1: Demonstration of the use of a ‘‘turn-ON’’ probe to reduce background signal in traumatic brain injury. Adapted with permission from (Li et al., 2020).
Copyright ª 2019, John Wiley and Sons.
Panel 2: Demonstration of ‘‘self-targeting’’ cell vesicle carriers for enhanced QD localization. Adapted with permission from (Zhang et al., 2019b). Copyright





Image-guided surgery (IGS) involves the useof intraoperative imagingmethods to aid the surgeon inperforming
the surgery. Some preoperative diagnostic methods such asMRI, PET, and SPECT are highly useful in tumor im-
aging; however, in practice these are difficult to apply during intraoperative procedures. Fluorescencemolecular
imaging is established as the clinical standard for IGS to aid in the resection of cancers, including breast cancer,
head/neck cancers, and lung cancer among other cancers (Mondal et al., 2014). NIR dyes offer advantages over
visible dyes in sensitivity as the autofluorescence from biological samples is negligible at NIR wavelengths (Hu
etal., 2018).Moreover, thefluorescenceemission ishighlypenetratingand, inmost cases, hasa longexcited-state
lifetime. Indocyanine green (ICG) and 5-aminolevulinic acid (5-ALA) are both FDA- and EMA-approvedNIR dyes
thathavebeenused intraoperatively tocarryout tumor resections.Theuseof ICGtoconduct intraoperative tumor
resections for breast cancer, skin cancer, and liver cancer has been demonstrated clinically, whereas 5-ALA has
primarily been utilized for the resection ofmalignant gliomas (Schaafsma et al., 2011; Stummer et al., 2006). How-
ever, thesedyes lackspecificity for the targetand therearesomemajor issues to tackle, especially for the resection
of brain tumors. For example, when using 5-ALA, IGSmust be conducted in the darkwith low-intensity blue light,
which risks damageof healthy brain tissues due to poor illumination. Recent developments of NIRQDs for in vivo
real-time imaginghave shownpotential for IGSduetocharacteristic properties suchasbrightness, photostability,
and low toxicity (Aswathy et al., 2010). Notably, NIR QDsmay be conjugated to biologically related components
such as peptides and known ligands for specificity of theQDs to its target; hence, the fluorescence is localized at
the exact site of resection that minimizes damage to surrounding tissues (Blanco-Canosa et al., 2014).
Over the past two decades, significant research has been published on the topic of NIR QDs for the appli-
cation of IGS of a range of cancers. Kim and Soltesz et al. were some of the first to publish their work with
NIR QDs for the sentinel lymph node (SLN) mapping of the lung and subsequent IGS, which was demon-
strated successfully on pigs (Kim et al., 2004; Soltesz et al., 2005). The core/shell CdTe/CdSe NIR QDs (d =
10 nm, lem = 860 nm, PLQY = 13%) were compared post-injection with a commonly used fluorescent dye,
isosulfan blue; here brighter fluorescence and significantly greater tissue penetration in comparison to the
dye was observed. Furthermore, only 200 pmol of the QDs was injected compared with 4 mL, 1% isosulfan
blue (approx. 70 nmol); this suggests a greater sensitivity and specificity for accurate IGS with a potential to
target non-small cell lung cancer (NSCLC) in the future. Similar lymph node mapping and dual IGS on 4T1
breast cancer mice was carried out by Tian et al. using PbS/CdS NIR II QDs (d = 20 nm, lem = >1500 nm,
PLQY = 6%) with an additional NIR II dye, emitting at >1500 nm and between 1100 and 1300 nm, respec-




Reviewconclusions of sensitivity, specificity, brightness, and tissue penetration were found superior in comparison
to the clinically approved ICG. In addition, a greater photostability than ICG was observed, as there was no
photobleaching after 5 h laser exposure, whereas it had only taken several minutes for visible photobleach-
ing in the case of ICG. Hence, this method allows for the feasibility of operating under bright light with
continuous laser exposure with a picomolar dose; this is not possible with traditional dyes.
Bioconjugation of CdTe/CdSe/ZnSe NIR QDs to anti-HER2 antibodies was published by Rizvi et al.; however,
only in vitro experiments were carried out to demonstrate the possibility of IGS of breast cancers. There have
been other reports of bioconjugatedCd-based NIRQDs that have been used for in vitro selectivity of other can-
cer cells, including liver cancer (Li et al., 2016), colon cancer, pancreatic cancer, and bladder cancer, suggesting
the uses for in vivo real-time imaging (Brunetti et al., 2018). However, there have been some concerns regarding
the safety of Cd-based NIR QDs, as Cd2+ released from the surface of the QDs has known issues of toxicity to
cells and tissues. There have been several reports on minimizing the impact of cytotoxicity, including the use of
polymeric coatings and other stabilizing ligands on the surface of the Cd-basedQD in the context of IGS. In vivo
toxicity experiments have been conductedonBALB/cmice by Liu et al. to show that theN-acetylcysteine (NAC)-
cappedCdHgTe/CdS/CdZnSQDs (d= 2.1G 0.6 nm, lem= 750 nm) have nomajor effects on the behavior of the
mice or the histology of tissues (Liu et al., 2018).
With the current limitations of intraoperative fluorescent molecular imaging for brain cancers, there is a sig-
nificant risk involved with the procedure. NIR QDs have shown potential to tackle these issues in the future
and have unique properties such as crossing the blood-brain barrier through carrier-mediated transport of
NPs. The concept of cadmium-free, CuInSe2/ZnS NIR QDs has recently been explored to alleviate concerns
of toxicity in a sensitive environment such as the brain (Liu et al., 2016). CGKRK peptide was chosen to con-
jugate to the QDs through PEG for specific targeting of p32 protein receptors overexpressed on tumor
endothelial cells. This research indicated a high photostability, specificity in targeting glioblastoma, and
minimal toxicity comparable to NIR dyes for IGS purposes. Some initial studies for real-time imaging of
glioblastoma tumors (U87MG) by Cai et al. utilized CdTe/ZnS NIR QDs (d = 15-21 nm, lem = 705 nm) con-
jugated with cRGD peptides through PEG to bind to the overexpressed avb3 integrin (Cai and Chen, 2008;
Cai et al., 2006). Here, the key finding showed >4-fold SNR increase from the bioconjugated NIR QD
compared with the non-conjugated NIR QD 6 h post-injection. This research was the basis of the work
by Li et al., where similar CdTe NIR QDs conjugated to cRGD (d = 4.5 nm, lem = 728 nm, PLQY = 38%)
were used to conduct the intraoperative resection of U87MG tumor bearing mice shown in Figure 9, Panel
1.
In contrast to ICG, which is non-specific and of lower quantum efficiency, bioconjugated NIR QDs have
shown here a proof of concept for use in image-guided surgery of glioblastoma (Li et al., 2012). A dual-mo-
dality imaging approach with the use of Gd-DOTA-Ag2S NIR II QDs (d = 20 nm, lem = 1200 nm) has been
employed by Li et al. for the purpose of preoperative detection with MRI and intraoperative NIR II image-
guided surgery on U87MG positive mice (Li et al., 2015). In this study, ICG was found to give a fluorescence
signal-to-noise ratio of up to 37, whereas the NIR II QDs gave a signal-to-noise of up to 334; furthermore,
the NIR II QD gave a T1 relaxivity of 4.9 mM
1 s1 and PLQY of 15%. Post-injection, MR signal in the brain
tumor peaked at 10 h and showed no changes in the histology of tissues, making it ideal for preoperative
detection and subsequent IGS (Figure 9, Panel 2).
NIR QDs have shown promise as superior alternatives to NIR dyes in the application of IGS, given by the
ongoing developments. Current research suggests the benefit of brightness, sensitivity, specificity, and
photostability will provide a significant advantage in IGS. The active targeting approach through bio-
conjugation and the ability to be utilized as multimodal agents gives endless possibilities for NIR QDs in
preoperative diagnostics and IGS. However, although toxicity concerns are addressed in literature, preclin-
ical studies may not provide the most accurate indication for the use of NIR QDs in clinical trials. In conclu-
sion, NIR QDs have demonstrated a proof-of-concept for IGS of cancers and show potential for clinical use
in one day providing a more accurate prognosis and an increase in successful resection of aggressive can-
cers such as glioblastoma.MULTIMODAL NIR QDS
Combining multiple, complementary, imaging modalities into a single moiety can be an effective method
to produce superior contrast agents. The high resolution and ability to be rapidly acquired makeiScience 24, 102189, March 19, 2021 17
Figure 9. Applications of NIR QDs in image-guided surgery
Panel 1: (A) In vivoNIR fluorescence imaging of U87MG tumor-bearingmice immediately after tail vein injection of cRGD-
NIR QD bioconjugates (a non-injected mouse used as blank control); (B) NIR imaging-guided surgery performed 48 h
after injection; and (C) the solid tumor precisely removed. Adapted with permission from (Li et al., 2012).
Panel 2: NIR-II fluorescence-guided brain tumor resection using Gd-Ag2S nanoprobe. (A) U87MG tumor-bearing mice
underwent craniotomy under isoflurane general anesthesia, and the tumor was excised step by step (top: NIR-II
fluorescence images; bottom: overlay images of brightfield and NIR-II fluorescence). Scale bar represents 2.5 mm. (B)
H&E-stained section of excised tumor tissue. (C) Flow cytometric histogram profiles of residual tumor cells. Adapted from




Reviewfluorescent imaging a valuable partner for other imaging techniques such as X-rays andMRI (Hemmer et al.,
2016). In turn, these modalities can improve the tissue penetration of the probe, allowing for improved
diagnosis prior to fluorescence-guided surgery or biopsy sampling.
QDs can be developed into multimodal imaging agents in a number of ways; the surface can be modified
with a variety of ligands, or they can be incorporated into larger particles containing other contrast agents
(Yang et al., 2019).
Bhardwaj et al. developed silver chalcogenide (Ag2X, X = S, Se) QDs emitting in the NIR-II region. Following




Reviewmodal MRI-fluorescence probe. Although they did not report any in vitro or in vivo applications, the authors
demonstrated the increase in MRI contrast agent efficacy that can be expected from this style of multi-
modal probe; the longitudinal relaxivity increased from 5.36 mM1 s1 (at 400 MHz) for the Gd chelate
on its own to 7.75 mM1 s1 and 8.27 mM1 s1 per Gd (at 400 MHz) when attached to the surface of
the Ag2S QDs. The overall relaxivity of the QD-Gd conjugate was recorded to be 407.8 mM
1 s1 and
990.3 mM1 s1 per QD (at 400 MHz)—this offers a potentially extremely high relaxivity per target, which
will improve the sensitivity of MRI (Bhardwaj et al., 2020).
This approach has proven popular for the development of high relaxivity MRI contrast agents in the past
(Stasiuk et al., 2011, 2013) and has the potential to produce effective dual modal contrast agents that can
provide both excellent anatomic resolution due to the MRI moiety and molecular concentration sensitivity
due to the fluorescent moiety (Bhardwaj et al., 2020). The combination of a small molecule MRI contrast
agent into a nanoparticle-based construct in this manner improves the contrast by localizing a high number
of contrast agents to increase the local relaxation rate and also by increasing the efficiency of the relaxation
achieved by these agents due to a slower rotational correlation coefficient. This effect can be seen by
measuring the relaxation rates at multiple magnetic field strengths. Whereas the small molecule probes
typically show a decrease in relaxivity around 4MHz, the nanoparticle-based agents show a distinct increase
in relaxivity, with amaxima around 40MHz, before decreasing again (Stasiuk et al., 2011, 2013). This is partic-
ularly useful for the development of clinically relevant agents, as typical clinical MRI scanners operate in the
range of 10s–100s of MHz so using QD-based MRI probes will further amplify the contrast gain.
Zhao et al. developed an amorphous Ag2-xCuxS system stabilized with BSA that displayed NIR emission,
photoacoustic imaging contrast, and photo thermal therapeutic properties. The amorphous nature of
these QDs is likely due to the low temperatures and long reaction times of the aqueous, BSA-assisted syn-
thesis. This dual modal imaging probe, combined with its therapeutic properties, produces a ‘‘theranostic’’
agent that can be used for imaging a malady, for treatment, and for monitoring treatment progress. By
absorbing light, the Ag2-xCuxS nanoparticles can produce heat, causing local hyperthermia and killing
the surrounding tissues—ideally the diseased tissue. To reduce the damage to healthy tissues it is impor-
tant to monitor the photothermal process carefully. The authors desired to include photoacoustic imaging
modalities into their theranostic nanoparticle to improve tissue penetration. The particles display a broad
absorbance across the visible and NIR range and an emission from 765 to 820 nm upon doping. The PLQY
and fluorescence intensity are reduced by doping, limiting the copper content to 1% to retain suitable NIR
fluorescent imaging properties. Both NIR fluorescence and photoacoustic imaging could be used to follow
uptake of the probe in vivo following tail vein injection into a mouse (Figures 10A and 10B). Uptake reached
a maximum within the tumor 8 h after intravenous injection, presumably due to the EPR effect. Following a
15-min laser irradiation (635 nm, 0.4 W cm2), localized temperature increase was observed within the tu-
mor reaching a maximum of 44C. In the irradiated animals, the volume of the tumors decreased signifi-
cantly over the 28-day monitoring period when compared with the probe alone or to laser irradiation alone
(Figure 10D). The nanoparticles had a long blood circulation half-life of 8.25 h—this allowed for the EPR
promoted accumulation with accumulation in the liver, spleen, and lung but gradually decreased from
the major organs after 1 day and was low after 7 days but still detectable (Zhao et al., 2020).CONCLUSIONS AND FUTURE PERSPECTIVES
In this review, we explored the most recent advances in NIR QDs, from synthetic methodologies, materials,
and properties to the most recent applications in biomedical imaging and from the heavy metal containing
nanoparticles such as Cd(II) or Pb(II) to the most promising Ag(I) and Cu(I) QDs (Table 1). Despite the great
advances that have been achieved in order to improve photophysical properties and make the QDs
compatible with biological systems, there are still challenges that have to be addressed, such as toxicity,
synthetic methodology, biological application, and ability to incorporate other imaging modalities, to
allow for the transition of NIR QDs to clinical practice.
a) Toxicity: one of the biggest concerns about the utilization of NIR QDs in biological systems is the toxicity
associated with the materials of the core. The toxicity and carcinogenic effects of free Cd(II) and Pb(II) ions
have been reported (Allocca et al., 2019; Sobhanan et al., 2020)—therefore, there is an inherent risk when
using these materials in NIR QDs. Toxicity studies report bioaccumulations in key organs such as liver,
spleen, lungs, and kidney for several days following injections. The potential damage to the organism could
be fatal if the chemical stability of the QDs is compromised, and although there are shelling strategies, theyiScience 24, 102189, March 19, 2021 19
Figure 10. Ag2-xCuxS system stabilized with BSA displaying multimodal properties in the NIR range
(A) In vivo NIR fluorescence images of a mouse after intravenous injection of a-Ag2-xCuxS QDs acquired at different detecting times under 635 nm
irradiation.
(B) In vivo PA images of a mouse before and after intravenous injection of a-Ag2-xCuxS QDs.
(C) In vivo IR images of mice (tumor sites) under various treatments.
(D) Relative tumor volume change of each group of mice (*p less than 0.05, n = 4).
(E) Body weight change curves of each group of mice (n = 4). (F) Histopathology of tumors with different treatment (scale bar represents 200mm). Adapted




Reviewdo not completely prevent leaching of the core ions. The strategies employed to reduce the leaching of
ions from the core involve shelling of the core with other materials such as zinc chalcogenides. Although
this strategy is proven to reduce the toxicity (Brunetti et al., 2013), more efficient methods of shelling
must be developed to ensure complete encapsulation of the cores and to improve stability. Encapsulation20 iScience 24, 102189, March 19, 2021
Table 1. Overview of the most recently synthesized NIR QDS, properties, synthetic methodologies, and biomedical applications
QDs (core/shell) Surface coatingEmission peak (nm) Size (nm)Quantum yield Synthetic methodologyBiomedical applications References
CdTe MPA 700–800 10 15%–20% Microwave In vivo KB cells tumor targeting (He et al., 2011)
CdTe/CdS MPA 710 10 –a Heat-up Ratiometric biosensor
for glucose detection
(Yu et al., 2017)
CdTe/CdS/ZnS GSH 730 8 45% Hydrothermal –b (Samanta et al., 2012)
CdAgS –a 700–800 7.20 36.13% Non-conventional –b (Órdenes-Aenishanslins et al., 2020)
CdHgTe Folate 790 6.68 –a Hydrothermal In vivo tumor imaging (Chen et al., 2011)
CQDs –a 615 4.54 84% Hydrothermal In vitro and in vivo two-
photon imaging with
various bio-samples
(Liu et al., 2020b)
CQDs PDA –a 25 5% Microwave Photothermal therapy (Bai et al., 2018)
CQDs –a 770 2–6 11% Microwave NIR up conversion luminescence imaging
in vivo
(Li et al., 2019b)
CQDs Chlorin e6 632–653 9.9 –a Hydrothermal Photothermal/photodynamic synergistic
cancer therapy
(Sun et al., 2019)
PbS MUA 1100 7.5 G
2.5
8% Hot-injection Imaging of the thrombotic
state in septic brain
(Imamura et al., 2016)
PbS/CdS anti-CD3
antibody
1600 17.1 6% Hot-injection Imaging-guided lymph node surgery (Tian et al., 2020)
PbS/CdS PEG 1600 18.2 2.2%–22% Hot-injection In vivo confocal 3D imaging of tumor
vasculature
(Zhang et al., 2018)
PbS/CdS/ZnS MPA 930-1220 5.7–6.2 30%–20% Hot-injection +
Microwave
In vivo tumor imaging (Ren et al., 2017)
Ag2S Gd chelates 1200 4.2 6% Heat-up Dual-modal MRI/NIR
imaging of brain tumors
(Bhardwaj et al., 2020)
Ag2S PEG 1135 8 –
a Hydrothermal Tracking of cerebral
vascular anomalies
(Parchur et al., 2020)
Ag2S PEG-PATU 1100 25–30 7.8% Hydrothermal In vivo imaging of the vasculature system (Awasthi et al., 2020)
Ag2S cRGDfK 500–1200 1.5–9 4.4%–22.7% Hydrothermal Integrin-targeted tumor imaging (Tang et al., 2015)
Ag2Se Glucose 775 2.4 G
0.5
3.1% Non-conventional In vivo long-term observation of tumor
evolution
(Ge et al., 2019)
Ag2Te PLGA 1300 106 G 2 2.3% Hot-injection In vivo Homotypic tumor imaging (Zhang et al., 2019b)
Ag2Te/Ag2S PEG 1560 5.71 4.3% Hot-injection Imaging of deep organs and
vascular structure
(Zhang et al., 2020)
CuInS2/ZnS MUA 1050 9.2 G 0.6 6.0% Hot-injection –
b (Xia et al., 2017)
Reported optical properties of the NIR QDs (emission, size, PLQY) refer to the QDs with the surface modification and in aqueous media
Abbreviations: MPA, mercaptopropionic acid; GSH, glutathione; PDA, polydopamine; MUA, mercaptoundecanoic acid; PEG, polyethylene glycol; PATU, polythiourea dendrimer; PLGA, poly(lactic-co-gly-
colic acid).
aThese data have not been disclosed by the authors of the study. In the case of CQDs, most synthesis do not report a surface coating given the as-synthesized biocompatibility















































Reviewof the QDs with silica polymers is another strategy used to prevent the leaching of toxic elements. Func-
tional organosilicon molecules are grafted onto the surface via -NH2 or -SH groups and provide additional
biocompatibility. The main challenges associated with silica coating are the difficulty in controlling the
thickness of the shell, often yielding larger QDs, with the PLQY usually decreasing after coating and the
emission peak suffering a blueshift in comparison with core only QDs (Du et al., 2016; Yang et al., 2010).
Although it has potential in improving core stability and biocompatibility, optimized silica coating meth-
odologies still have to be developed.
Ag(I) and Cu(I), although being recent developments in NIR QDs, have quickly reached good optical prop-
erties when compared with the more studied materials above, with emissions reaching NIR-II windows. The
low toxicity and improved biocompatibility (Aydemir et al., 2020; Vardar et al., 2018) of thesematerials have
been the main drive for a gradual research shift toward these NIR QDs. This shift is clear by the growing
number of preclinical studies recently published, with this material highlighting the excellent NIR emission
and PLQY, good chemical stability, and biocompatibility. Carbon-based NIR QDs while receiving much
attention because of the almost inexistent toxicity, still fall far behind of the other described materials.
The methods used for the synthesis yield QDs that have difficulties finding the NIR-I window, and the re-
ported PLQY are lower in comparison with Ag(I) or Cu(I) NIR QDs.
For the future, synthetic procedures should focus on Ag(I) and Cu(I) NIR QDs to yield more biocompatible
NIR QDs without compromising the optical properties.
b) Synthesis: the synthetic methodologies are the key to tuning NIR QDs optical properties. Despite
continuous advances in this area, synthetic methods that yield NIR QDs in aqueous media with high
biocompatibility still present weaker fluorescence properties. The hot-injection and heat-up methods
are still the most used procedures because they yield QDs with higher PLQY and chemical stability. The
synthesized QDs are in organic media; to make them biologically compatible they must undergo phase
transfer and/or ligand exchange protocols. The current procedures for performing these steps reduce
the PLQY and hinders emission in the NIR region.
The material coating has also shown to be one essential consideration in the synthesis of NIR QDs for bio-
logical targeting. Coating with PEG chains of various sizes is the most used approach; the non-specific tar-
geting nature of these molecules has enabled the tracking of individual blood cells or metastatic tumor
cells and in the future can be a viable tool to detect bacterial infections or immune responses. More specific
targeting molecules have been incorporated into QDs, such as antibodies or peptides, and these allow for
increased uptake, and longer retention, of the QDs in target tissues allowing for an increased signal-to-
noise ratio (SNR) to be obtained, thus improving image quality.
As challenges for the future, more efficient hydrothermal or microwave routes need to be designed tomake
the synthesis as consistent as the standard hot-injection methodology, with a focus on one-pot reactions
for QDs in aqueous media. In the same sense, the phase transfer protocols can also be further optimized
with QDs obtained from hot injection and heat up methods, to improve PLQY.
c) Biomedical applications: NIRQDs havebeen used toguide therapies—through diagnosis, image-guided sur-
gery, and theranostic applications. One of the most promising applications of NIR QDs is imaging-guided sur-
gery (IGS) due to the higher tissuepenetration, PLQY, andphotostability, which otherNIRmolecular probes lack.
The specificity of these probes allows for a more selective excision of the affected tissue while minimizing the
damage to the surrounding healthy tissue. Pre-clinical studies have been conducted, testing the application
of NIR QDs for the IGS of several tissues, such as sentinel lymph node, breast cancer, and glioblastoma. The re-
sults are encouraging for NIR QDs as they successfully enabled the removal of the targeted tumor. When in
direct comparison with clinically used dyes, such as ICG or 5-ALA, NIR QDs enable the surgeon to clearly distin-
guish the affected area from the background as a result of the higher SNR.
NIR QDs have also been used in theranostic applications. Current theranostic applications include photo-
thermal therapy, taking advantage of the charge/electron transfers in the emission of NIR fluorescence to
destroy target tumors. The main challenge for the future would be to develop QDs with high specificity for
each disease, through engineering of the QDs surface, which would be an improvement to the existing




Reviewd)Multimodal QDs: the development of multimodal approaches that combine the benefits of fluorescence
with other imaging modalities is one of the most promising developments for the future of NIR QDs.
Coupling MRI agents to NIR QDs has been reported successfully (Bhardwaj et al., 2020; Ma et al., 2018).
Nonetheless, the difference in sensitivity of both techniques implies that a high ratio of MRI contrast agent
to fluorescent probe would be beneficial. This can be achieved with QDs; a high number of MRI contrast
agents can be loaded onto the surface of each QD. PET has also been paired with fluorescent imaging,
benefiting from the high tissue penetration of PET and high resolution of fluorescence imaging. One of
the limitations of multimodal imaging is the use of different equipment to detect the reportingmechanisms
at the same time. One of the challenges would be the optimization of the concentration of each individual
imaging agent in the multimodal probe. Currently, trimodal probes such as NIR fluorescent imaging/MRI/
PET have yet to be developed and would be a welcome addition to multimodal imaging, given the poten-
tial to explore this synergetic technique.
The list of materials for the synthesis of NIR QDs is varied (Table 1), and the field will benefit from an invest-
ment in less-toxic alternatives, replacing the more well-studied materials. With the focus on the improve-
ment of the synthetic methodologies, this would allow for the synthesis of materials with improved and
controlled properties, such as size dispersion, NIR emission peak, and PLQY. The improvement of the shel-
ling and surface coating procedures will improve the chemical stability of the cores, addressing the toxicity
concerns that QDs still face and improving the clearance of these nanoparticles from the organism. After
addressing these core issues, these improved NIR QDs will replace the Cd and Pb materials, and then they
will be able to make the transition from the preclinical to a clinical setting, creating new tools for diagnosis
and treatment of several diseases.
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Á.J., and Vetrone, F. (2017). Development and
investigation of ultrastable pbs/cds/zns quantum
dots for near-infrared tumor imaging. Part Part
Syst. Charact 34, 1600242.
Resch-Genger, U., Grabolle, M., Cavaliere-
Jaricot, S., Nitschke, R., and Nann, T. (2008).
Quantum dots versus organic dyes as fluorescent
labels. Nat. Methods 5, 763.
Saikia, D., Chakravarty, S., Sarma, N.,
Bhattacharjee, S., Datta, P., and Adhikary, N.
(2017). Aqueous synthesis of highly stable cdte/
zns core/shell quantum dots for bioimaging.
Luminescence 32, 401–408.
Samanta, A., Deng, Z., and Liu, Y. (2012). Aqueous
synthesis of glutathione-capped cdte/cds/zns
and cdte/cdse/zns core/shell/shell nanocrystal
heterostructures. Langmuir 28, 8205–8215.
Sarkar, S., Le, P., Geng, J., Liu, Y., Han, Z., Zahid,
M.U., Nall, D., Youn, Y., Selvin, P.R., and Smith,
A.M. (2020). Short-wave infrared quantum dots
with compact sizes as molecular probes for
fluorescence microscopy. J. Am. Chem. Soc. 142,
3449–3462.
Schaafsma, B.E., Mieog, J.S.D., Hutteman, M.,
Van der Vorst, J.R., Kuppen, P.J., Löwik, C.W.,
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